Interleukin-6 protects anterior horn neurons from lethal virus-induced injury.
We evaluated the role of interleukin-6 (IL-6) in neuronal injury after CNS infection. IL-6-/- and IL-6+/+ mice of resistant major histocompatibility complex (MHC) H-2b haplotype intracerebrally infected with Theiler's virus cleared the infection normally without development of viral persistence, lethal neuronal infection, or late phase demyelination. In contrast, infection of IL-6-/- mice on a susceptible H-2q haplotype resulted in frequent deaths and severe neurologic deficits within 2 weeks of infection as compared with infected IL-6+/+ H-2q littermate controls. Morphologic analysis demonstrated dramatic injury to anterior horn neurons of IL-6-/- H-2q mice at 12 d after infection. Infectious viral titers in the CNS (brain and spinal cord combined) were equivalent between IL-6-/- H-2q and IL-6+/+ H-2q mice. In contrast, more viral RNA was detected in the spinal cord of IL-6-/- mice compared with IL-6+/+ H-2q mice. Virus antigen was localized predominantly to anterior horn cells in infected IL-6-/- H-2q mice. IL-6 deletion did not affect the humoral response directed against virus, nor did it affect the expression of CD4, CD8, MHC class I, or MHC class II in the CNS. Importantly, IL-6 was expressed by astrocytes of infected IL-6+/+ mice but not in astrocytes of IL-6-/- mice or uninfected IL-6+/+ mice. Furthermore, expression of various chemokines was robust at 12 d after infection in both H-2b and H-2q IL-6-/- mice, indicating that intrinsic CNS inflammatory responses did not depend on the presence of IL-6. Finally, in vitro analysis of virus-induced death in neuroblastoma-spinal cord-34 motor neurons and primary anterior horn cell neurons showed that IL-6 exerted a neuroprotective effect. These data support the hypothesis that IL-6 plays a critical role in protecting specific populations of neurons from irreversible injury.
Pavelko
Kevin D
KD
Department of Immunology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Howe
Charles L
CL
Drescher
Kristen M
KM
Gamez
Jeff D
JD
Johnson
Aaron J
AJ
Wei
Tao
T
Ransohoff
Richard M
RM
Rodriguez
Moses
M
D000818:Animals; D000870:Anterior Horn Cells / Q000187:drug effects* / Q000473:pathology / Q000821:virology; D000917:Antibody Formation / Q000235:genetics / Q000276:immunology; D001253:Astrocytes / Q000378:metabolism / Q000473:pathology; D001921:Brain / Q000378:metabolism / Q000473:pathology; D018188:Cardiovirus Infections / Q000473:pathology* / Q000821:virology; D016923:Cell Death; D004195:Disease Models, Animal; D018450:Disease Progression; D018792:Encephalitis, Viral / Q000276:immunology / Q000473:pathology* / Q000821:virology; D005802:Genes, MHC Class II / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000276:immunology; D007113:Immunity, Innate / Q000235:genetics / Q000276:immunology; D015850:Interleukin-6 / Q000096:biosynthesis / Q000235:genetics / Q000494:pharmacology*; D051379:Mice; D008815:Mice, Inbred Strains; D018345:Mice, Knockout; D009046:Motor Neurons / Q000187:drug effects / Q000473:pathology / Q000821:virology; D013116:Spinal Cord / Q000378:metabolism / Q000473:pathology; D016019:Survival Analysis; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology; D017945:Theilovirus / Q000276:immunology / Q000472:pathogenicity*; D014779:Virus Replication
D015395:Histocompatibility Antigens Class I; D015850:Interleukin-6